Endometriosis and Ovarian Cancer-Reply

JAMA · 2024 · vol. 332(24) , pp. 2117 · doi:10.1001/jama.2024.21911 · PMID:39621324 · W4404905127
Other OA: closed CC0 ⤵ 2 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

This paper is a reply regarding endometriosis and ovarian cancer, likely addressing previous points or research in the field.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (6)

Cited by (3)

Source provenance

europepmc
last seen: 2026-10-27T06:12:01.810347+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-27T06:09:11.480675+00:00
License: CC0 · commercial use OK